SONIDEGIB

SynDRA canonical compound SYN0031598 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx
Primary target(s)	SMO
Mechanism of action	Smoothened receptor antagonist
Indication	basal cell carcinoma (BCC)
Disease area	oncology

All known targets

sonidegib diphosphate
odomzo
LDE225
erismodegib
LDE-225
NPV-LDE-225
sonidegib phosphate
NVP-LDE-225
NVP-LDE225
Erismodegib
Odomzo
LDE 225
Sonidegib (LDE-225)
LDE225 (NVP-LDE225,Erismodegib)
0RLU3VTK5M
LDE225 Diphosphate
956697-53-3 (free base)
N-(6-((2S,6R)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)biphenyl-3-carboxamide
N-(6-((cis-2,6-Dimethylmorpholin-4-yl)-3-pyridyl)-2-methyl-3-(4-(trifluoromethoxy)phenyl)benzamide
Odomozo
N-(6-((2R,6S)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide
n-(6-((2r,6s)-2,6-dimethylmorpholino)pyridin-3-yl)-2-methyl-4'-(trifluoromethoxy)biphenyl-3-carboxamide
N-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridin-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide
N-[6-[(2S,6R)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide
Sonidegib [USAN:INN]
UNII-0RLU3VTK5M
Erismodegib [USAN:INN]
Sonidegib phospate
(1,1'-Biphenyl)-3-carboxamide, N-(6-((2R,6S)-2,6-dimethyl-4-morpholinyl)-3-pyridinyl)-2- methyl-4'-(trifluoromethoxy)-, rel-
[1,1'-Biphenyl]-3-carboxamide, N-[6-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4'-(trifluoromethoxy)-, rel-
LDE225 (NVP-LDE225; Erismodegib)
SONIDEGIB [INN]
SONIDEGIB [MI]
Sonidegib (USAN/INN)
SONIDEGIB [USAN]
erismodegib (deleted INN)
SONIDEGIB [WHO-DD]
NVP-LDE225(Erismodegib)